Authors: Kanetsky, PA Holmes, R Walker, A Najarian, D Swoyer, J Guerry, D Halpern, A Rebbeck, TR

Citation: Pa. Kanetsky et al., Interaction of glutathione S-transferase M1 and T1 genotypes and malignantmelanoma, CANC EPID B, 10(5), 2001, pp. 509-513

Authors: Wildemore, JK Schuchter, L Mick, R Synnestvedt, M Elenitsas, R Bedrosian, I Czerniecki, BJ Guerry, D Lessin, SR Elder, DE Bucky, LP

Citation: Jk. Wildemore et al., Locally recurrent malignant melanoma characteristics and outcomes: A single-institution study, ANN PL SURG, 46(5), 2001, pp. 488-494

Authors: Bedrosian, I Faries, MB Guerry, D Elenitsas, R Schuchter, L Mick, R Spitz, FR Bucky, LP Alavi, A Elder, DE Fraker, DL Czerniecki, BJ

Citation: I. Bedrosian et al., Incidence of sentinel node metastasis in patients with thin primary melanoma (<= 1 mm) with vertical growth phase, ANN SURG O, 7(4), 2000, pp. 262-267

Authors: Christos, PJ Oliveria, SA Berwick, M Guerry, D Elder, DE Synnestvedt, M Fine, JA Barnhill, RL Halpern, AC

Citation: Pj. Christos et al., Signs and symptoms of melanoma in older populations, J CLIN EPID, 53(10), 2000, pp. 1044-1053

Authors: Somasundaram, R Robbins, P Moonka, D Loh, E Marincola, F Patel, A Guerry, D Herlyn, D

Citation: R. Somasundaram et al., CD4(+), HLA class I-restricted, cytolytic T-lymphocyte clone against primary malignant melanoma cells, INT J CANC, 85(2), 2000, pp. 253-259

Authors: Van Belle, PA Elenitsas, R Satyamoorthy, K Wolfe, JT Guerry, D Schuchter, L Van Belle, TJ Albelda, S Tahin, P Herlyn, M Elder, DE

Citation: Pa. Van Belle et al., Progression-related expression of beta 3 integrin in melanomas and nevi, HUMAN PATH, 30(5), 1999, pp. 562-567